Additionally, LPS is an activator of toll-like receptor 4 (TLR4), and the activation of downstream signaling pathways (including nuclear factors-κB (NF-κB) pathway and MAPK pathway) enhances the invasion and migration of cancer cells [26,27]. Here, TLR4 is linked to cancer.